Zio XT ECG Monitoring System vs Eko Low Ejection Fraction Tool (ELEFT)
AI Verdict
Choose Zio XT ECG Monitoring System if…
Choose the Zio XT ECG Monitoring System if you require continuous, long-term cardiac rhythm monitoring for up to 14 days to detect and diagnose intermittent arrhythmias that may not be evident during a brief clinical encounter. This system is ideal for patients needing comprehensive assessment of their heart's electrical activity over an extended period, offering high patient compliance with its comfortable, wearable design.
View Zio XT ECG Monitoring System →Choose Eko Low Ejection Fraction Tool (ELEFT) if…
Choose the Eko Low Ejection Fraction Tool (ELEFT) if you need a rapid, non-invasive screening tool to aid in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical examinations. This AI-powered solution integrates seamlessly with Eko digital stethoscopes, providing quick insights within approximately 15 seconds to help identify at-risk patients in a primary care or general cardiology setting.
View Eko Low Ejection Fraction Tool (ELEFT) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Zio XT ECG Monitoring System | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Pricing | Contact for pricing | Unknown |
| Deployment | Cloud-based (AWS EC2 platform), no on-premise hardware required. | Unknown |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Zio XT ECG Monitoring SystemTool A (Zio XT) offers superior patient usability for extended monitoring with its wearable, wire-free, and water-resistant design, leading to high patient compliance (up to 99%). While Tool B (ELEFT) provides quick results for clinicians, Tool A addresses more complex usability challenges for long-term patient engagement and data collection.
Clinical Value
Zio XT ECG Monitoring SystemTool A (Zio XT) provides comprehensive, continuous cardiac monitoring for up to 14 days, significantly increasing the diagnostic yield for intermittent arrhythmias. While Tool B (ELEFT) offers valuable early detection of low ejection fraction, Tool A's extended monitoring capability covers a broader range of cardiac diagnostic needs.
Pricing & Value
Zio XT ECG Monitoring SystemTool A (Zio XT) provides specific pricing examples for the UK (u00a3310 per patient) and US Medicare rates (approximately $229-$260.35), offering greater transparency. Tool B (ELEFT) only states 'contact for pricing' and that it's part of an enterprise platform, making it harder to assess its value proposition without direct inquiry.
Enterprise Readiness
Eko Low Ejection Fraction Tool (ELEFT)Both tools are cloud-based, FDA-cleared, HIPAA compliant, and offer BAAs, indicating strong foundational enterprise readiness. However, Tool B (ELEFT) explicitly states it is part of Eko's SENSORAu2122 platform, an 'enterprise solution,' suggesting a more deliberate design and packaging for large-scale organizational deployments.
Innovation
Zio XT ECG Monitoring SystemTool A (Zio XT) demonstrates significant innovation in patient-friendly, long-duration ambulatory cardiac monitoring with its wire-free, water-resistant biosensor and high patient compliance. While Tool B (ELEFT) innovates by bringing AI-powered heart failure screening to the point of care, Tool A's advancements in continuous, comfortable, and highly compliant diagnostics for extended periods represent a broader innovation in wearable medical technology.
Support & Docs
TieNeither the provided structured facts nor general web searches reveal a significant differentiator in the quality or extent of support and documentation offered by either company. Both iRhythm Technologies and Eko Health, as established medical device companies, appear to provide standard support resources, FAQs, and contact information for healthcare professionals and patients.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Zio XT ECG Monitoring System | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Tool Name | Zio XT ECG Monitoring System | Eko Low Ejection Fraction Tool (ELEFT) |
| Company | iRhythm Technologies | Eko Health |
| Primary Function | Wearable, single-lead ECG biosensor for up to 14 days of continuous cardiac monitoring, utilizing FDA-cleared AI and expert review for accurate arrhythmia detection and diagnosis. | FDA-cleared AI algorithm that integrates with Eko digital stethoscopes to aid clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams. |
| Key Technology/Sensor | Wearable single-lead ECG biosensor (Zio biosensor) | AI algorithm integrated with FDA-cleared Eko digital stethoscopes |
| Monitoring Duration/Time to Result | Continuous ambulatory cardiac monitoring for up to 14 days | Provides results in approximately 15 seconds |
Videos
Demos, reviews, and walkthroughs featuring Zio XT ECG Monitoring System and Eko Low Ejection Fraction Tool (ELEFT).
Frequently Asked Questions
More Comparisons
More matchups featuring Zio XT ECG Monitoring System or Eko Low Ejection Fraction Tool (ELEFT)
Backers
Who funded each tool's parent company.